摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

苯并[d]噁唑-2-甲醇 | 77186-95-9

中文名称
苯并[d]噁唑-2-甲醇
中文别名
——
英文名称
benzo[d]oxazol-2-ylmethanol
英文别名
(1,3-benzoxazol-2-yl)methanol;1,3-benzoxazol-2-ylmethanol
苯并[d]噁唑-2-甲醇化学式
CAS
77186-95-9
化学式
C8H7NO2
mdl
MFCD07368333
分子量
149.149
InChiKey
MFAYHDNWECITJF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    263.6±23.0 °C(Predicted)
  • 密度:
    1.315±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    46.3
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934999090
  • 危险性防范说明:
    P280,P305+P351+P338,P310
  • 危险性描述:
    H302,H315,H319,H332,H335

SDS

SDS:fae5dd8358d7a7ffc3642557f5c87af6
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Benzo[d]oxazol-2-ylmethanol
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Benzo[d]oxazol-2-ylmethanol
CAS number: 77186-95-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H7NO2
Molecular weight: 149.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    苯并[d]噁唑-2-甲醇咪唑三苯基膦 作用下, 以 二氯甲烷 为溶剂, 反应 0.25h, 生成 2-iodomethylbenzoxazole
    参考文献:
    名称:
    Samarium Barbier Reactions of α-Iodomethyloxazoles and Thiazoles with Aliphatic Aldehydes
    摘要:
    The reductive coupling of substituted alpha-iodomethyloxazoles and thiazoles with aliphatic aldehydes under Barbier conditions provides an effective method for the direct incorporation of intact heterocyclic systems.
    DOI:
    10.1021/ol051345v
  • 作为产物:
    参考文献:
    名称:
    Skraup; Moser, Chemische Berichte, 1922, vol. 55, p. 1097
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • [EN] HERBICIDAL ISOXAZOLO[5,4-B]PYRIDINES<br/>[FR] ISOXAZOLO[5,4-B]PYRIDINES HERBICIDES
    申请人:BASF SE
    公开号:WO2012010633A1
    公开(公告)日:2012-01-26
    The invention relates to isoxazolo[5,4-b]pyridine compounds of formula (I), to the agriculturally useful salts of isoxazolo[5,4-b]pyridine compounds of formula (I), and to their use as herbicides.
    这项发明涉及式(I)的异噁唑并[5,4-b]吡啶化合物,以及式(I)的异噁唑并[5,4-b]吡啶化合物的农业上有用的盐,以及它们作为除草剂的用途。
  • Asymmetric Coupling of Carbon‐Centered Radicals Adjacent to Nitrogen: Copper‐Catalyzed Cyanation and Etherification of Enamides
    作者:Guoyu Zhang、Song Zhou、Liang Fu、Pinhong Chen、Yibiao Li、Jianping Zou、Guosheng Liu
    DOI:10.1002/anie.202008338
    日期:2020.11.9
    The first copper‐catalyzed asymmetric cyanation and etherification reactions of enamides have been established, where a carbon‐centered radical adjacent to a nitrogen atom (CRAN) is enantioselectively trapped by a chiral copper(II) species. Moreover, the asymmetric cyanation of vinyl esters was disclosed as well. These reactions feature very mild reaction conditions and high functional group tolerance
    已经建立了第一个催化的酰胺类不对称化和醚化反应,其中与氮原子(CRAN)相邻的碳中心自由基被手性(II)物种对映选择性地捕获。此外,还公开了乙烯基酯的不对称化。这些反应具有非常温和的反应条件和较高的官能团耐受性,并提供了一系列手性的α-基酰胺,α-基酯和α-半胱酸,收率高,对映选择性优异。手性α-基酰胺很容易转化为对映体富集的1,2-二胺和氨基酸
  • Aryl Radical Activation of C–O Bonds: Copper-Catalyzed Deoxygenative Difluoromethylation of Alcohols
    作者:Aijie Cai、Wenhao Yan、Wei Liu
    DOI:10.1021/jacs.1c04254
    日期:2021.7.7
    direct use of free alcohols without purification of the xanthate esters. Mechanistic studies are consistent with the hypothesis of aryl radicals being formed and initiating the cleavage of the C–O bonds of xanthate esters, to generate alkyl radicals as the key intermediates. This aryl radical activation approach represents a new strategy for the activation of alcohols as cross-coupling partners.
    鉴于其在天然产物和药物中的普遍存在,醇是构建 C-C 键最有吸引力的起始材料之一。我们在此报告了第一个利用芳基的反应性来激活醇衍生的黄原酸酯中的 C-O 键的催化策略,从而发现了第一个催化脱氧二甲基化反应。在催化条件下,很容易从醇原料合成的各种烷基黄原酸酯被催化生成的芳基活化,并通过烷基中间体转化为烷基二氟甲烷产物。这种可扩展的协议具有广泛的底物范围和官能团耐受性,能够对复杂的药剂进行后期修饰。已开发出一种一锅法,允许直接使用游离醇而无需纯化黄原酸酯。机理研究与芳基自由基形成并引发黄原酸酯的 C-O 键断裂以产生作为关键中间体的烷基自由基的假设一致。这种芳基自由基活化方法代表了一种将醇作为交叉偶联物活化的新策略。
  • NOVEL 3-HYDROXY-5-ARYLISOTHIAZOLE DERIVATIVE
    申请人:Okano Akihiro
    公开号:US20120157459A1
    公开(公告)日:2012-06-21
    [Problem] To provide a GPR40 activating agent having, as an active ingredient, a novel compound having a GPR40 agonist action, a salt of the compound, a solvate of the salt or the compound, or the like, particularly, an insulin secretagogue and a prophylactic and/or therapeutic agent against diabetes, obesity, or other diseases. [Means of solving the problem] A compound of Formula (I): (where n is 0 to 2; p is 0 to 4; j is 0 to 3; k is 0 to 2; a ring A is an aryl group which is optionally substituted with L or a heterocyclic group which is optionally substituted with L; a ring B is a benzene ring, a pyridine ring, or a pyrimidine ring; X is O, S, —NR 7 —; and R 1 to R 7 are specific groups), a salt of the compound, or a solvate of the salt or the compound.
    提供一个以新型化合物作为活性成分的GPR40激活剂,该化合物具有GPR40激动剂作用,该化合物的盐,该盐或化合物的溶剂合物,或者类似物,尤其是胰岛素分泌促进剂以及对糖尿病、肥胖症或其他疾病的预防及/或治疗剂。[解决该问题的方法] 公式(I)的化合物:(其中n为0至2;p为0至4;j为0至3;k为0至2;环A是一个芳基团,可选择性被L取代或是一个杂环团,可选择性被L取代;环B是一个苯环、一个吡啶环或一个嘧啶环;X是O,S,—NR7—;R1至R7是特定基团),该化合物的盐,或该盐或化合物的溶剂合物。
  • NITROGEN-CONTAINING TRICYCLIC DERIVATIVE HAVING HIV REPLICATION INHIBITORY ACTIVITY
    申请人:Shionogi & Co., Ltd.
    公开号:EP3305789A1
    公开(公告)日:2018-04-11
    The present invention provides a novel compound having antiviral activity, especially HIV replication inhibitory activity and a medicament containing the same. The compound represented by the formula: wherein A3 is CR3A, CR3A R3B, N or NR3C; R3A, R3B, R4A and R4B are each independently a hydrogen atom, halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted alkynyl, or substituted or unsubstituted non-aromatic carbocyclyl; R3C is a hydrogen atom, substituted or unsubstituted alkyl, or substituted or unsubstituted non-aromatic carbocyclyl; ring T1 is substituted or unsubstituted nitrogen-containing non-aromatic heterocycle; R1 is a hydrogen atom, halogen, cyano, or substituted or unsubstituted alkyl; R2 is each independently substituted or unsubstituted alkyl or the like: n is 1 or 2; R3 is substituted or unsubstituted aromatic carbocyclyl or the like; R4 is a hydrogen atom or a carboxy protecting group.
    本发明提供了一种具有抗病毒活性的新型化合物,特别是具有抑制HIV复制活性的化合物和含有该化合物的药物。该化合物由以下式表示: 其中A3为CR3A、CR3A R3B、N或NR3C;R3A、R3B、R4A和R4B分别独立地为氢原子、卤素、基、取代或未取代的烷基、取代或未取代的炔基,或取代或未取代的非芳香碳环烷基;R3C为氢原子、取代或未取代的烷基,或取代或未取代的非芳香碳环烷基;环T1为取代或未取代的含氮非芳香杂环;R1为氢原子、卤素、基,或取代或未取代的烷基;R2分别为取代或未取代的烷基或类似物;n为1或2;R3为取代或未取代的芳香碳环烷基或类似物;R4为氢原子或羧基保护基。
查看更多

同类化合物

(N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) 钙离子载体A23187半镁盐 钙离子载体A23187半钙盐 萘并[2,3-d]噁唑-2,8(3H,5H)-二酮,6,7-二氢-5-甲基- 萘并[2,3-d]噁唑-2,5-二酮,3,6,7,8-四氢-3,8-二甲基- 荧光增白剂EBF 苯并恶唑胺 苯并恶唑的取代物 苯并恶唑甲磺酰氯 苯并恶唑基-2-甲酰基-S-乙基-异缩氨基硫脲 苯并恶唑-2-羧酸酰肼 苯并恶唑-2-磺酸 苯并恶唑-2-甲酸 苯并恶唑-2-甲磺酸钠 苯并恶唑-2-乙酸 苯并恶唑 苯并噁唑-5-甲酸 苯并噁唑-2-羧酸乙酯 苯并噁唑-2-甲醛 苯并噁唑,5,7-二(1,1-二甲基乙基)-2-乙烯基- 苯并噁唑,5,7-二(1,1-二甲基乙基)-2-乙基- 苯并噁唑,4,7-二氯-2-(氯甲基)- 苯并噁唑,2-叠氮- 苯并噁唑,2-(氯甲基)-4,7-二氟- 苯并[d]恶唑-7-甲酸甲酯 苯并[d]恶唑-5-硼酸频哪醇酯 苯并[d]噁唑-6-甲醛 苯并[d]噁唑-2-羧酸甲酯 苯并[d]噁唑-2-甲醇 苯并[D]恶唑-7-胺 苯并[D]噁唑-4-基氨基甲酸叔丁酯 苯并[D]噁唑-2-羧酸钾 苯并-13C6-噁唑 离子载体 碘化二氢2-[3-(5,6-二氯-1,3-二乙基-1,3--2H-苯并咪唑-2-亚基)丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 硫代偏糖醛 甲酰胺,N-乙基-N-[6-[(3-甲酰基苯氧基)甲基]-2-苯并噁唑基]- 甲酰胺,N-[6-(溴甲基)-2-苯并噁唑基]-N-乙基- 甲基硫酸1-甲基-8-[(甲基氨基甲酰)氧代]喹啉正离子 甲基6-氨基-1,3-苯并恶唑-2-羧酸酯 甲基2-氨基-1,3-苯并恶唑-5-羧酸酯 甲基1,3-苯并恶唑-2-基乙酸酯 甲基-2-乙基-1,3-苯并唑-5-羧酸乙酯 甲基-1,3-苯并唑-5-羧酸乙酯 环戊二烯并[e][1,3]恶嗪-5,6-二胺 环戊二烯并[d][1,3]恶嗪-6,7-二胺 溴氯唑酮 溴化二氢2-[3-[1-[4-[(乙酰氨基)磺基基]丁基]-5,6-二氯-3-乙基-1,3--2H-苯并咪唑-2-亚基]丙-1-烯基]-3-乙基-5-苯基苯并噁唑正离子 氰基二硫代亚氨酸(6-氯-2-氧代-3(2H)-苯并恶唑基)甲基甲基酯 氰基-二硫代亚氨酸甲基(2-氧代-3(2H)-苯并恶唑基)甲基酯